Danaparoid
Top View
- Treatment of Heparin-Induced Thrombocytopenia: What Are the Contributions of Clinical Trials?
- Thrombosis and Anticoagulation
- 9/28/2020 1 Use of Direct-Acting Oral Anticoagulants in Heparin- Induced Thrombocytopenia
- Dalteparin Sodium(BAN, USAN, Rinn) Danaparoid Sodium(BAN
- Anticlotting Mechanisms 2: Pharmacology and Clinical Implications
- Heparin-Induced Thrombocytopenia (Hit)
- Danaparoid for Heparin-Induced Thrombocytopenia
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Package Leaflet
- Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia
- Neuraxial Blockade and Anticoagulation
- Warfarin-Induced Skin Necrosis and Venous Limb Gangrene in the Setting of Heparin-Induced Thrombocytopenia
- Standard Heparin, Low Molecular Weight Heparin, Low Molecular Weight Heparinoid, and Recombinant Hirudin Differ in Their Ability
- Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach
- Failure of Danaparoid Anticoagulation for Cardiopulmonary Bypass
- Tinzaparin Sodium: a Low-Molecular-Weight Heparin (Printe
- Diagnosis & Management of Heparin-Induced Thrombocytopenia
- Summary of Product Characteristics